ADAM BERGIN: Open Payments
NPI 1538537378 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 27 payments from 13 companies in 2025. Trend: 2023 $378 · 2024 $1,440 · 2025 $727
Food & beverage: $627Education: $100
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 6 | $200 |
| Janssen Biotech, Inc. | 4 | $162 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $74 |
| ABBVIE INC. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Lilly USA, LLC | 1 | $29 |
| UCB, Inc. | 1 | $25 |
| Botanix SB Inc | 1 | $25 |
| LEO Pharma Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
Products named: Zoryve, TREMFYA, DUPIXENT, SKYRIZI, ILUMYA, TALTZ, Bimzelx, SOFDRA.
Industry payments across FL — which companies pay providers there.
